One of them had some valuation concerns, though. Analysts at UBS increased their price target on the semiconductor company’s shares to $240  from $195, citing the company's 2020 product cycle and its multiple.Seymore boosted his price target to $190 from $160, which is still below the company's nearly $208 closing price Friday. The analyst views tailwinds in NVDA's ability to address a wide range of rapidly growing sectors (artificial intelligence, data center, gaming, advanced driver assistance systems/audio-visual, etc.

Burlington Stores stock coverage was initiated by an RBC Capital analyst with an outperform rating. RBC Capital analyst Kate Fitzsimmons expects the off-price department store retailer to continue to narrow its margin gap relative to peers, particularly under the leadership of a new CEO. Michael O'Sullivan came in as chief executive of Burlington in September.The analyst has set a price target at $230 for the shares. 

Walmart (NYSE: WMT) is scheduled to report earnings before the open this Thursday, November 14 and that will kick off a stretch of big earnings reports from various retailers over a short period of time.Over the course of five trading days we will get reports from Walmart, Home Depot (NYSE: HD), Kohls (NYSE: KSS), TJX Companies (NYSE: TJX), Lowes (NYSE: LOW), and Target (NYSE: TGT). The six stocks listed are from different segments of the retail industry, but we see in the table below that there are some really good fundamental and technical statistics for the group as a whole.

The sector has been trending higher over the last month as those earnings reports have been released, but many of the stocks are now in overbought territory based on their daily stochastic readings.On November 7, four of top six holdings in the VanEck Vectors Oil Services ETF (NYSE: OIH) appeared on a bearish scan that I run each night.

Twilio got a re-affimed rating from RBC Capital analyst . RBC Capital analyst Alex Zukin reiterated his outperform rating on shares of the cloud communications platform as a service company."In terms of the election, while guidance for next year will include some contribution, if all political campaigns were considered together and all used Twilio (both of which are very aggressive assumptions), it could be a 10% customer," Zukin wrote.  

Qualcomm stock got downgraded Morgan Stanley analysts, sending the shares lower on Monday. Morgan Stanley analysts reduced their rating on the semiconductor company to equal weight from overweight, while indicating that the stock's valuation gap relative to its industry peers has closed following recent gains.He hiked his price target on the stock to $90 from $89. Faucette suggested that Qualcomm shares’ momentum in recent months amid tariff uncertainties coupled  with an antitrust lawsuit by the Federal Trade Commission currently being appealed by Qualcomm would mean that potential positive opportunities will likely take longer to have a substantial effect on results.

Facebook's Instagram will begin testing hiding "likes" from U.S. viewers next week. At the Wired25 conference, Instagram CEO Adam Mosseri announced, "We're testing making like counts private".Mosseri also said, “We will make decisions that hurt the business if they help people’s well-being and health”.

Gap Inc. lowered its full-year earnings outlook.The FactSet consensus estimate is $1.86 per share. CFO Teri List-Stoll cited macro impacts and slower traffic as additional headwinds to results that have been affected by “product and operating challenges across key brands”. Separately, Gap announced that Art Peck is leaving the company.

Sea Limited (NYSE: SE) is an electronic gaming and multimedia company based in Singapore.With the negative readings in these key indicators, the Tickeron SMR rating for Sea Ltd. is 100, the worst rating a company can get.

One such company is Immunomedics (Nasdaq: IMMU), a clinical-stage biopharmaceutical company. The company has lost money in each of the last three years and the losses have been increasing rather than decreasing.I know that is a rather large range, but the stock jumped from $4 to $16 in 2017. What got my attention about Immunomedics currently was the pattern in the candlestick chart on November 6.

Chinese travel website operator Trip.com International (Nasdaq: TCOM) has seen its stock trend lower since peaking just above $60 in July 2017.The company is set to report earnings on November 13 and investors will be hoping the company can break out of its downward trend. Analysts expect the company to report earnings of $0.29 per share for the quarter and that is down 31% from the $0.42 the company earned a year ago.

On Thursday, Expedia reported quarterly earnings that lagged analysts' expectations. The online travel company’s earnings came in at $3.38 a share for the third quarter, falling short of $3.82 estimate of analysts surveyed by Zacks Investment Research, and below $3.79-a-share estimate of analysts polled by FactSet.But the figure is higher than the $3.28 billion the company reported during the same quarter in 2018. Expedia’s operating income declined -9% year-over-year to $609 million. Hotel bookings grew at  +11% in the quarter, which is a slower rate compared to +13% a year before, as indicated by the company.

Shares of Lowe's got a rating upgrade from a Credit Suisse analyst, who also raised the price target on the stock. Credit Suisse analyst Seth Sigman increased his rating on the home improvement retail chain’s shares  to outperform from neutral.Under Ellison’s leadership, Lowe’s has shuttered more than 40 underperforming stores, and retrenched thousands of assembly jobs at stores that involved putting together grills and patio furniture, choosing to contract instead with third party vendors.

On Wednesday, Wendy's reported higher-than-expected third-quarter earnings, on the back of strong same-store sales growth. The fast-food restaurant chain’s adjusted earnings before income, taxes, depreciation and amortization came in at $109.9 million, or 19 cents a share on an adjusted basis.The systemwide same-store sales grew +5.5%. For the full year, Wendy's  now expects adjusted earnings growth in the range between negative -1.5% and positive 1.5% (from its prior guidance of between a drop of -3.5% and -6.5%). The company projects full-year total sales of between $12 billion and $12.5 billion, and adjusted EBITDA of approximately $425 million to $435 million.    

The healthcare company also boosted its full-year profit guidance. The company’s  adjusted earnings for the three months ending in September came in at $1.84 per share, higher than analyst’ estimate of $1.77 per share.The figure reflects growth of +6.35% from the same period last year.  CVS total revenues surged +36.5% year-over-year to $64.8 billion in the quarter, again exceeding analysts' expectation of $63 billion. On a segment level, Pharmacy Services revenues rose +6.5%, on brand name drug price inflation as well as increased total pharmacy claims volume, partially offset by continued price compression and an increased generic dispensing rate – as indicated by the company.

Retailer Ross Stores (Nasdaq: ROST) saw its stock double in value from mid-2017 through the middle of this year.Sure there were some up and down cycles along the way, but the overall trend in the stock has been to upside for over two years. Looking at the daily chart we see how the stock has been trending higher since the end of May and has been riding its 50-day moving average higher over the last four months.

Bausch Health posted third-quarter revenue that surpassed analysts’ expectations.The company also boosted its revenue guidance. In the third quarter, the pharmaceutical company’s revenue increased to $2.21 billion ( from $2.14 billion a year earlier), beating analysts’ estimate of $2.16 billion. Bausch reported a loss of -$49 million, or -14 cents a share - compared to a loss of -$350 million, or -$1 a share in the year-ago quarter. Adjusted net income for the quarter came in at $425 million, up from $403 million a year earlier. Looking ahead, Bausch Health now expects a revenue range of $8.475 billion to $8.625 billion for the full-year 2019, up from its previous guidance of $8.4 billion to $8.6 billion. CEO Joseph Papa emphasized on the strength of the company's long-standing brands, Xifaxan, BioTrue Oneday and Bausch + Lomb Ultra, as well as successful performances of newer products, such as Lumify and Thermage.

Marvell Technology got a rating boost from Wells Fargo. Analysts at Wells Fargo raised their rating on the  semiconductor company to outperform from market perform. Wells Fargo  also hiked the target price on the shares was also hiked to $32 a share from $25, which represents a 27% upside from Marvell's closing price Friday of $25.14. "MRVL should continue to experience robust 5G base station-related sales to Nokia and Samsung for the balance of 2019 and into 2020," Analyst Gary Mobely wrote. Mobely is also hopeful that data-center capital expenditures would rise, which in turn should augur well for MRVL's Octeon/Nitrox and Fibre Channel sales (according to the analyst).

McDonald's shares got downgraded Piper Jaffray, following the firing of CEO Steve Easterbrook. Easterbrook has to leave the company because his consensual relationship with an employee violated company policy.“Our experience leads us to take a more cautionary view noting the potential lack of momentum and time involved in formalizing a new team,” Piper Jaffray wrote. However, Piper Jaffray also mentioned that their change in rating does not reflect McDonald's overall ability to “dominate in terms of global market scale, the effectiveness of its leadership team, or the effort behind its franchise network”.

Casino operator Wynn Resorts (Nasdaq: WYNN) is set to report third quarter earnings results on November 6 and the stock will be looking to break out of a downward trend with the results. The stock has been trending lower since peaking in April and if we connect the high from April and July, we get a downward sloped trend line that is currently just below $130.It would take a pretty big drop to get the stock back down to this area after the earnings report, but that could happen over the course of the coming weeks. You can attribute the decline in the stock price to the fundamentals of the company.